Login / Signup

A nanocrystal-based formulation improves the pharmacokinetic performance and therapeutic response of albendazole in dogs.

Alejandro Javier ParedesNicolás LitterioAlicia DibDaniel Alberto AllemandiCarlos LanusseSergio Sánchez BruniSantiago Daniel Palma
Published in: The Journal of pharmacy and pharmacology (2017)
The improved pharmacokinetic performance observed for the novel formulation of ABZ correlated with an improved in vivo therapeutic response against a model intestinal nematode parasite in dogs.
Keyphrases
  • drug delivery